![Michael Kalb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kalb
Financieel Directeur/CFO bij
CATALYST PHARMACEUTICALS, INC.
Vermogen: 426 758 $ op 31-05-2026
Profiel
Michael W.
Kalb is Chief Financial Officer & Executive Vice President at Catalyst Pharmaceuticals, Inc. since 2024.
Former roles include Executive VP, Chief Financial & Accounting Officer at CinCor Pharma, Inc. from 2022 to 2023; Chief Financial Officer at IPI Legacy Liquidation Co. in 2023; Chief Financial Officer & Senior Vice President at Amarin Corp.
Plc from 2016 to 2022; Chief Financial & Accounting Officer, Group VP at Taro Pharmaceutical Industries Ltd. from 2013 to 2016; Chief Financial Officer at Taro Pharmaceuticals U.S.A., Inc.; and Director-Accounting & Financial Consulting Group at Huron Consulting Group, Inc. Education includes undergraduate studies at State University of New York at Albany.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 13.665 ( 0,01% ) | 426 758 $ | 31-05-2026 |
Actieve functies van Michael Kalb
| Bedrijven | Functie | Begin |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 01-01-2024 |
Eerdere bekende functies van Michael Kalb
| Bedrijven | Functie | Einde |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Financieel Directeur/CFO | 31-12-2023 |
| CINCOR PHARMA, INC. | Financieel Directeur/CFO | 01-03-2023 |
| AMARIN CORPORATION PLC | Financieel Directeur/CFO | 20-06-2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Financieel Directeur/CFO | 29-06-2016 |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - |
Opleiding van Michael Kalb
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
43
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Taro Pharmaceutical Industries Ltd.
 Taro Pharmaceutical Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company that engages in therapies and generic medicines | Health Services |
Huron Consulting Group, Inc.
 Huron Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare, business advisory and education services | Commercial Services |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Manufactures and sells generic pharmaceutical products | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
